Save the date! Open activity RESILIENCE in Thursday November 7th
In the framework of the Madrid Science and Innovation Week to be celebrated in Madrid on November 4-17th, our team RESILIENCE has planned an activity open to public of all ages upon registration. There will be a workshop and roundtable under the title “What is the relationship between cardiovascular disease and cancer?”. The participants in […]
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity
Anthracyclines, alone or in combination, remain the first-line therapy for many cancers, including various forms of lymphoma, breast cancer, leukaemia, melanoma, and uterine and gastric cancers. Every year, anthracyclines are administered to >3 million European citizens to treat a first cancer. The curative potential of anthracycline therapy is determined by appropriate dosing. Anthracyclines have a […]
